• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于强直性脊柱炎与中性粒细胞与淋巴细胞比值的临床研究的系统评价和荟萃分析。

A Systematic Review and Meta-analysis of Clinical Studies on Ankylosing Spondylitis and Neutrophil to Lymphocyte Ratio.

机构信息

Evidence-Based Medicine Research Group, Mashhad University of Medical Sciences, Mashhad, Iran.

Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Curr Rheumatol Rev. 2022;18(2):160-167. doi: 10.2174/1573397117666210921114431.

DOI:10.2174/1573397117666210921114431
PMID:34548002
Abstract

BACKGROUND

Neutrophil to lymphocyte ratio (NLR) is a marker for many inflammatory diseases. Ankylosing spondylitis (AS) is among these inflammatory diseases, and many studies have compared the NLR ratio between patients with AS and healthy controls.

AIM

This study aims to systematically review and analyze the available evidence about the significance of NLR values in AS.

METHOD

Based on Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines, we searched Embase, Pubmed, ISI Web of Science, and Scopus databases from inception to August 2020 using ("Ankylosing spondyl* " OR "Bechterew Disease" OR "Rheumatoid Spondylitis") AND ((neutrophil* AND lymphocyte*) OR NLR) as key terms of the search strategy. Data selection and extraction were conducted separately by two authors. We appraised the included articles according to the Joanna Briggs checklist. Comprehensive Meta-analysis Version 2 was used for analysis and assessment of publication bias. I2 > 75% and p-value < 0.05 were considered significant.

RESULT

In total, 182 studies resulted from a search in all databases. Duplicate removal, title, abstract, and full-text screening yielded 12 related studies, with 11 included in the meta-analysis. Quality assessment was satisfying in all studies. Pooled difference in NLR means value between patients and controls was 0.38 (95% CI: 0.24-0.52, p-value <0.0001). An I2 of 51% and a Cochran Q test p-value of <0.05 indicated moderate heterogeneity; thus, subgroup analysis had no indication. Publication bias was not significant (Funnel plot with an Egger's intercept of -0.07; p-value=0.95).

CONCLUSION

Significant higher amounts of NLR may be strongly indicative of underlying inflammation in AS.

摘要

背景

中性粒细胞与淋巴细胞比值(NLR)是许多炎症性疾病的标志物。强直性脊柱炎(AS)就是其中一种炎症性疾病,许多研究比较了 AS 患者和健康对照者的 NLR 比值。

目的

本研究旨在系统回顾和分析 NLR 值在 AS 中的意义的现有证据。

方法

根据观察性研究的荟萃分析(MOOSE)指南,我们使用“强直性脊柱炎”或“Bechterew 病”或“类风湿性脊柱炎”和(中性粒细胞和淋巴细胞或 NLR)作为搜索策略的关键词,从建库开始至 2020 年 8 月在 Embase、Pubmed、ISI Web of Science 和 Scopus 数据库中进行检索。数据选择和提取由两位作者分别进行。我们根据 Joanna Briggs 清单对纳入的文章进行评估。综合 Meta 分析版本 2 用于分析和评估发表偏倚。I2>75%和 p 值<0.05 被认为具有统计学意义。

结果

总共从所有数据库中搜索到 182 项研究。通过重复去除、标题、摘要和全文筛选,得到 12 项相关研究,其中 11 项纳入荟萃分析。所有研究的质量评估均令人满意。患者和对照组 NLR 均值差值为 0.38(95%CI:0.24-0.52,p 值<0.0001)。I2 为 51%,Cochran Q 检验 p 值<0.05,表明存在中度异质性;因此,亚组分析没有指示。发表偏倚不显著(漏斗图 Egger 截距为-0.07;p 值=0.95)。

结论

AS 中 NLR 值明显升高可能强烈提示存在潜在炎症。

相似文献

1
A Systematic Review and Meta-analysis of Clinical Studies on Ankylosing Spondylitis and Neutrophil to Lymphocyte Ratio.一项关于强直性脊柱炎与中性粒细胞与淋巴细胞比值的临床研究的系统评价和荟萃分析。
Curr Rheumatol Rev. 2022;18(2):160-167. doi: 10.2174/1573397117666210921114431.
2
Neutrophil lymphocyte ratio in patients with ankylosing spondylitis: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值在强直性脊柱炎患者中的变化:一项系统评价和荟萃分析。
Mod Rheumatol. 2020 Jan;30(1):141-148. doi: 10.1080/14397595.2018.1564165. Epub 2019 Apr 23.
3
Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.中性粒细胞/淋巴细胞和血小板/淋巴细胞比值作为强直性脊柱炎患者疾病活动度的潜在标志物:一项病例对照研究
Adv Rheumatol. 2020 Jan 29;60(1):13. doi: 10.1186/s42358-020-0113-5.
4
The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.中性粒细胞/淋巴细胞比值与类风湿关节炎和强直性脊柱炎疾病活动度之间的关联
J Clin Lab Anal. 2016 Sep;30(5):597-601. doi: 10.1002/jcla.21908. Epub 2015 Dec 14.
5
Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis.中性粒细胞与淋巴细胞比值与强直性脊柱炎的治疗选择及炎症标志物相关
J Clin Lab Anal. 2015 Jul;29(4):294-8. doi: 10.1002/jcla.21768. Epub 2014 May 21.
6
Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.根治性肾输尿管切除术治疗上尿路上皮癌患者术前淋巴细胞相关系统性炎症生物标志物的预后价值:系统评价和荟萃分析。
World J Surg Oncol. 2020 Oct 23;18(1):273. doi: 10.1186/s12957-020-02048-7.
7
Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值在类风湿关节炎和强直性脊柱炎中的比较。
J Coll Physicians Surg Pak. 2024 Jan;34(1):68-72. doi: 10.29271/jcpsp.2024.01.68.
8
Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.术前中性粒细胞与淋巴细胞比值对肾细胞癌的预后价值:系统评价和荟萃分析。
BMC Urol. 2020 Jul 6;20(1):90. doi: 10.1186/s12894-020-00665-8.
9
Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis.中性粒细胞与淋巴细胞比值对成人脓毒症患者预后和死亡风险的预测价值:一项荟萃分析。
Front Immunol. 2024 Mar 18;15:1336456. doi: 10.3389/fimmu.2024.1336456. eCollection 2024.
10
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio and disease activity in rheumatoid arthritis: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与类风湿关节炎的疾病活动度:系统评价和荟萃分析。
Eur J Clin Invest. 2023 Feb;53(2):e13877. doi: 10.1111/eci.13877. Epub 2022 Sep 24.

引用本文的文献

1
Neutrophil-Lymphocyte Ratio in Fibromyalgia and Axial Spondyloarthritis: A Potential Biomarker for Diagnosis and Disease Activity.纤维肌痛和轴性脊柱关节炎中的中性粒细胞与淋巴细胞比值:一种用于诊断和疾病活动度的潜在生物标志物
Biomedicines. 2025 Jun 18;13(6):1497. doi: 10.3390/biomedicines13061497.
2
Monitoring disease activity and treatment response in ankylosing spondylitis: a retrospective study of hematologic inflammatory markers.强直性脊柱炎疾病活动度及治疗反应的监测:血液学炎症标志物的回顾性研究
Rheumatol Int. 2024 Dec 28;45(1):10. doi: 10.1007/s00296-024-05763-6.
3
Application of neutrophil to lymphocyte ratio in ankylosing spondylitis: Based on bibliometric and visualization analysis.
中性粒细胞与淋巴细胞比值在强直性脊柱炎中的应用:基于文献计量学和可视化分析。
Medicine (Baltimore). 2024 May 31;103(22):e38364. doi: 10.1097/MD.0000000000038364.
4
CARD9 in the pathogenesis of axial spondyloarthritis.CARD9 在轴性脊柱关节炎发病机制中的作用。
Best Pract Res Clin Rheumatol. 2024 May;38(2):101964. doi: 10.1016/j.berh.2024.101964. Epub 2024 Jun 19.
5
Evaluation of the relationship between blood cell markers and inflammation, disease activity, and general health status in ankylosing spondylitis.评估强直性脊柱炎患者血细胞标志物与炎症、疾病活动度和总体健康状况之间的关系。
Rev Assoc Med Bras (1992). 2023 Sep 18;69(10):e20230722. doi: 10.1590/1806-9282.20230722. eCollection 2023.
6
High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis.高基线中性粒细胞与淋巴细胞比值可作为强直性脊柱炎患者肿瘤坏死因子-α阻滞剂及其停药的生物标志物。
Pharmaceuticals (Basel). 2023 Mar 1;16(3):379. doi: 10.3390/ph16030379.
7
Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives.中性粒细胞与淋巴细胞比值与多发性硬化症的相关性:最新认识及潜在应用前景
Neurol Res Int. 2022 Oct 26;2022:3265029. doi: 10.1155/2022/3265029. eCollection 2022.